| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 102029-74-3 | L-Isoleucine, L-tyrosyl-L-prolyl-L-phenylalanyl-L-valyl-L-a-glutamyl-L-prolyl-; L-Isoleucine, N-[1-[N-[N-[N-(1-L-tyrosyl-L-prolyl)-L-phenylalanyl]-L-valyl]-L-a-glutamyl]-L-prolyl]-; 17: PN:WO2006017688 SEQID: 65 unclaimed sequence; 18: PN: WO0239997 SEQID: 23unclaimed sequence; 49: PN: WO2006068768 SEQID: 47 claimed sequence; 619: PN:US20090175821 SEQID: 745 claimed protein; 91: PN: WO0069900 SEQID: 745unclaimed sequence; 97: PN: WO0069900 SEQID: 753 unclaimed sequence; Human b-casomorphin 7; b-Casomorphin (human); b-Casomorphin-7(human) |  | C44H61N7O11 | 详情 | 供应商 | |
| 149440-24-4 | L-leucine,D-tyrosyl-L-glutaminyl-L-tryptophyl-L-alanyl-L-valylglycyl-L-histidyl-, methylester (9CI); Ranatensin,1-de(5-oxo-L-proline)-2-de-L-valine-3-D-tyrosine-10-L-leucine-11-de-L-methioninamide-,methyl ester |  | C48H66N12O11 | 详情 | 供应商 | |
| 126985-98-6 | L-Argininamide,L-alanyl-L-prolyl-L-leucyl-L-serylglycyl-L-phenylalanyl-L-tyrosylglycyl-L-valyl-; LocustatachykininII; Lom-TK II |  | C50H76N14O12 | 详情 | 供应商 | |
| 121520-99-8 | L-tyrosine,N-[N-[N-[N-[N-(1-acetyl-L-prolyl)-L-phenylalanyl]-L-histidyl]-L-leucyl]-L-valyl]-(9CI); AG 84-10 |  | C42H56N8O9 | 详情 | 供应商 | |
| 141677-18-1 | L-valine,L-leucyl-L-leucyl-L-phenylalanylglycyl-L-tyrosyl-L-prolyl-L-valyl-L-tyrosyl-; L-valine,N-[N-[N-[1-[N-[N-[N-(N-L-leucyl-L-leucyl)-L-phenylalanyl]glycyl]-L-tyrosyl]-L-prolyl]-L-valyl]-L-tyrosyl]-; 10: PN: WO02102299 SEQID: 10 unclaimed protein; 10: PN: WO9960119 PAGE: 79unclaimed protein; 121: PN: WO03070752 SEQID: 121 claimed protein; 14: PN:WO2008120203 SEQID: 14 unclaimed sequence; 152: PN: WO0100225 TABLE: 6 claimedprotein; 17: PN: WO9964597 SEQID: 17 unclaimed protein; 18: PN: WO0025813SEQID: 18 unclaimed protein; 1: PN: US20060111551 SEQID: 1 claimed sequence; 1:PN: WO03076585 SEQID: 1 claimed protein; 1: PN: WO2004084838 PAGE: 19 claimedprotein; 1: PN: WO2004092373 SEQID: 1 unclaimed protein; 21: PN: WO2004044004SEQID: 21 claimed protein; 244: PN: US20020007173 SEQID: 285 unclaimed protein; 287: PN: US6994851 SEQID: 286 unclaimed sequence; 28: PN: WO2008120202 SEQID:26 claimed sequence; 306: PN: WO2006071990 SEQID: 306 unclaimed sequence; 34:PN: WO2009125395 SEQID: 44 unclaimed protein; 3: PN: US20030003535 SEQID: 3unclaimed protein; 3: PN: US20040191260 SEQI |  | C56H79N9O12 | 详情 | 供应商 | |
| 156761-76-1 | L-alanine,L-tyrosyl-L-leucyl-L-a-glutamyl-L-prolylglycyl-L-prolyl-L-valyl-L-threonyl-; L-alanine,N-[N-[N-[1-[N-[1-[N-(N-L-tyrosyl-L-leucyl)-L-a-glutamyl]-L-prolyl]glycyl]-L-prolyl]-L-valyl]-L-threonyl]-; 10: PN: US6312684 SEQID: 10 claimed sequence; 115: PN: WO2004071457 SEQID: 142unclaimed sequence; 116: PN: US7420037 SEQID: 121 unclaimed protein; 1262: PN:WO2006091734 PAGE: 71 claimed sequence; 13: PN: WO03024480 PAGE: 84 unclaimedsequence; 15: PN: WO03047506 SEQID: 15 unclaimed sequence; 16: PN: WO2005004907SEQID: 16 unclaimed sequence; 18: PN: US6660276 SEQID: 14 claimed sequence; 18:PN: WO2004102198 SEQID: 44 claimed sequence; 18: PN: WO2008019018 SEQID: 16unclaimed sequence; 19: PN: US20070048860 SEQID: 3 unclaimed sequence; 19: PN:WO2008120202 SEQID: 5 claimed sequence; 1: PN: US20060188469 SEQID: 14unclaimed sequence; 1: PN: WO0009145 SEQID: 10 unclaimed sequence; 1: PN:WO2009013018 SEQID: 1 claimed sequence; 24: PN: WO0200914 SEQID: 25 unclaimedsequence; 24: PN: WO2008054611 TABLE: 2 unclaimed sequence; 251: PN:WO2009109428 SEQID: 255 claimed protein; 26: PN: WO0 |  | C44H67N9O14 | 详情 | 供应商 | |
| 166090-74-0 | H-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA-OH | H-ASP-ala-GLU-PHE-ARG-HIS-ASP-SER-GLY-tyr-GLU-val-HIS-HIS-GLN-LYS-leu-val-PHE-PHE-ala-GLU-ASP-val-GL; PREDOMINANT AMYLOID B-proTEIN FRAGMENT; ASP-ala-GLU-PHE-ARG-HIS-ASP-SER-GLY-tyr-GLU-val-HIS-HIS-GLN-LYS-leu-val-PHE-PHE-ala-GLU-ASP-val-GLY-SER-ASN-LYS-GLY-ala-ILE-ILE-GLY-leu-MET-val-GLY-GLY-val-val-ILE-ala; ASP-ala-GLU-PHE-GLY-HIS-ASP-SER-GLY-PHE-GLU-val-ARG-HIS-GLN-LYS-leu-val-PHE-PHE-ala-GLU-ASP-val-GLY-SER-ASN-LYS-GLY-ala-ILE-ILE-GLY-leu-MET-val-GLY-GLY-val-val-ILE-ala; BAP 1-42; BETA-AMYLOID, SODIUM SALT; BETA-AMYLOID PEPTIDE (1-40), MOUSE, RAT; BETA-AMYLOID PEPTIDE (1-40), RAT; BETA-AMYLOID PEPTIDE (1-42), RAT | 无 | C203H311N55O60S | 详情 | 供应商 |
| 96249-43-3 | EGF RECEPTOR (985-996) (HUMAN) | ASP-val-val-ASP-ala-ASP-GLU-tyr-leu-ILE-pro-GLN; EPIDERMAL GROWTH FACTOR RECEPTOR (985-996) (HUMAN); EPIDERMAL GROWTH FACTOR RECEPTOR PEPTIDE (985-996); EPIDERMAL GROWTH FACTOR RECEPTOR PEPTIDE (985-996) (HUMAN); EPIDERMAL GROWTH FACTOR RECEPTOR PEPTIDE (HUMAN); EGF RECEPTOR (985-996) (HUMAN); EGF RECEPTOR PEPTIDE (985-996) (HUMAN); H-ASP-val-val-ASP-ala-ASP-GLU-tyr-leu-ILE-pro-GLN-OH; ASP-val-val-ASP-ala-ASP-GLU-tyr-leu-ILE-pro-GLN |  | C61H93N13O23 | 详情 | 供应商 |
| 125093-93-8 | VIP ANTAGONIST | H-LYS-pro-ARG-ARG-pro-tyr-THR-ASP-ASN-tyr-THR-ARG-leu-ARG-LYS-GLN-MET-ala-val-LYS-LYS-tyr-leu-ASN-SE; H-LYS-pro-ARG-ARG-pro-tyr-THR-ASP-ASN-tyr-THR-ARG-leu-ARG-LYS-GLN-MET-ala-val-LYS-LYS-tyr-leu-ASN-SER-ILE-leu-ASN-NH2; KPRRPYTDNYTRLRKQMAVKKYLNSILN-NH2; VASOACTIVE INTESTINAL PEPTIDE ANTAGONIST; VIP ANTAGONIST; (lys1,pro2,5,arg3,4,tyr6)-vasoactive*intestinal P; (LYS1 pro2 5 ARG3 4 tyr6)-VASOACTIVE &; (VIP-neurotensin) hybrid antagonist; H-Lys-pro-Arg-Arg-pro-tyr-Thr-Asp-Asn-tyr-Thr-Arg-leu-Arg-Lys-Gln-Met-ala-val-Lys-Lys-tyr-leu-Asn-Ser-Ile-leu-Asn-NH2 |  | C154H257N49O40S | 详情 | 供应商 |
| 383415-79-0 | TRP-tyr-LYS-HIS-val-ala-SER-pro-ARG-tyr-HIS-THR-val-GLY-ARG-ala-ala-GLY-leu-leu-MET-GLY-leu | H-TRP-tyr-LYS-HIS-val-ala-SER-pro-ARG-tyr-HIS-THR-val-GLY-ARG-ala-ala-GLY-leu-leu-MET-GLY-leu-OH; NPW-23 (HUMAN); NEUROPEPTIDE W-23 (HUMAN); TRP-tyr-LYS-HIS-val-ala-SER-pro-ARG-tyr-HIS-THR-val-GLY-ARG-ala-ala-GLY-leu-leu-MET-GLY-leu; H-TRP-tyr-LYS-HIS-val-ala-SER-pro-ARG-tyr-HIS-THR-val-GLY-ARG-ala-ala-GLY-leu-leu-MET-GLY-leu-OH |  | C119H183N35O28S | 详情 | 供应商 |
| 120944-72-1 | GLY-ala-pro-val-pro-tyr-pro-ASP-pro-leu-GLU-pro-ARG | GLY-ala-pro-val-pro-tyr-pro-ASP-pro-leu-GLU-pro-ARG; OSTEOCALCIN (7-19) (HUMAN); OSTEOCALCIN, FRAGMENT 7-19; OSTEOCALCIN FRAGMENT 7-19 HUMAN; GLY-ala-pro-val-pro-tyr-pro-ASP-pro-leu-GLU-pro-ARG; GAPVPYPDPLEPR; [GLU17]-OSTEOCALCIN (7-19) (HUMAN); H-GLY-ala-pro-val-pro-tyr-pro-ASP-pro-leu-GLU-pro-ARG-OH |  | C65H98N16O19 | 详情 | 供应商 |
| 75976-10-2 | 人体胰脏多肽 | PANCREATIC POLYPEPTIDE, HUMAN; H-ala-pro-leu-GLU-pro-val-tyr-pro-GLY-ASP-ASN-ala-THR-pro-GLU-GLN-MET-ala-GLN-tyr-ala-ala-ASP-leu-ARG-ARG-tyr-ILE-ASN-MET-leu-THR-ARG-pro-ARG-tyr-NH2; APLEPVYPGDNATPEQMAQYAADLRRYINMLTRPRY-NH2; ala-pro-leu-GLU-pro-val-tyr-pro-GLY-ASP-ASN-ala-THR-pro-GLU-GLN-MET-ala-GLN-MET-ala-GLN-tyr-ala-ala-ASP-leu-ARG-ARG-tyr-ILE-ASN-MET-leu-THR-ARG-pro-ARG-tyr-NH2; ala-pro-leu-GLU-pro-val-tyr-pro-GLY-ASP-ASN-ala-THR-pro-GLU-GLN-MET-ala-GLN-tyr-ala-ala-ASP-leu-ARG-ARG-tyr-ILE-ASN-MET-leu-THR-ARG-pro-ARG-tyr-NH2; ala-pro-leu-GLU-pro-val-tyr-pro-GLY-ASP-ASN-ala-THR-pro-GLU-GLN-MET-ala-GLN-tyr-ala-ala-ASP-leu-ARG-ARG-tyr-ILE-ASN-MET-leu-THR-ARG-pro-ARG-tyr-NH2 HUMAN; PP, HUMAN; PANCREATIC POLYPEPTIDE; PANCREATIC POLYPEPTIDE, HUMAN |  | C185H287N53O54S2 | 详情 | 供应商 |
| 136461-80-8 | tyr-leu-tyr-GLN-TRP-leu-GLY-ala-pro-val-pro-tyr-pro-ASP-pro-leu-GLA-pro-ARG-ARG-GLA-val-CYS-GLA-leu- | H-tyr-leu-tyr-GLN-TRP-leu-GLY-ala-pro-val-pro-tyr-pro-ASP-pro-leu-GLA-pro-ARG-ARG-GLA-val-CYS-GLA-LE; OSTEOCALCIN (HUMAN, GLA17,21,24); OSTEOCALCIN (1-49) (HUMAN); tyr-leu-tyr-GLN-TRP-leu-GLY-ala-pro-val-pro-tyr-pro-ASP-pro-leu-GLA-pro-ARG-ARG-GLA-val-CYS-GLA-leu-ASN-pro-ASP-CYS-ASP-GLU-leu-ala-ASP-HIS-ILE-GLY-PHE-GLN-GLU-ala-tyr-ARG-ARG-PHE-tyr-GLY-pro-val; YLYQWLGAPVPYPDPL-GLA-PRR-GLA-VC-GLA-LNPDCDELADHIGFQEAYRRFYGPV; H-tyr-leu-tyr-GLN-TRP-leu-GLY-ala-pro-val-pro-tyr-pro-ASP-pro-leu-GLA-pro-ARG-ARG-GLA-val-CYS-GLA-leu-ASN-pro-ASP-CYS-ASP-GLU-leu-ala-ASP-HIS-ILE-GLY-PHE-GLN-GLU-ala-tyr-ARG-ARG-PHE-tyr-GLY-pro-val-OH; [GLA17,21,24]-OSTEOCALCIN (1-49); GLA17,21,24-OSTEOCALCIN (HUMAN); BONE GLA proTEIN (HUMAN) | 无 | 详情 | 供应商 | |
